Here is a comprehensive account of the connection between bile salts and blood cholesterol, drawn from authoritative textbooks.
Bile Salts and Blood Cholesterol: The Core Connection
1. Bile Acids Are Made From Cholesterol
The liver converts cholesterol into bile acids — this is the principal route of cholesterol elimination from the body. Cholesterol, a lipophilic molecule, is converted into water-soluble bile acids in pericentral hepatocytes via two major pathways:
- Classical (neutral) pathway — initiated by cholesterol 7α-hydroxylase (CYP7A1), the rate-limiting enzyme; favours cholic acid (CA)
- Alternative (acidic) pathway — initiated by sterol 27-hydroxylase (CYP27A1); favours chenodeoxycholic acid (CDCA)
Under normal physiology, about 0.2–0.6 g/day of bile acids are synthesised, consuming cholesterol as substrate. This can be upregulated to 4–6 g/day after intestinal resection.
"Total body cholesterol metabolism is managed predominantly by the liver; the two principal pathways by which cholesterol is eliminated are cholesterol excretion and bile acid synthesis from cholesterol."
— Yamada's Textbook of Gastroenterology
2. The Hepatocyte Is the Central Hub
The diagram below shows how cholesterol flows in the hepatocyte:
Cholesterol (CH) enters the hepatocyte from blood via LDL receptors (LDLR), HDL via SR-BI, and chylomicron remnants via CMRR. It is then biosynthesised (via HMGCR from acetate), esterified for storage (ACAT), used to form VLDL/HDL, or catabolised into bile salts (BS) by CYP7A1/CYP27A1 — and secreted into bile via ABCB11.
— Sleisenger and Fordtran's Gastrointestinal and Liver Disease
3. The Enterohepatic Circulation: A Feedback Loop That Regulates Blood Cholesterol
0.5 g bile acids synthesised/day from cholesterol; total pool ~4 g cycling 6–8 times per day. Ileal Na-dependent active transport returns >95% to the liver; ~0.5 g lost in stool daily.
— Harrison's Principles of Internal Medicine 22E
Key features:
- >95% of bile salts are reabsorbed in the terminal ileum via the apical sodium-dependent bile acid transporter (ASBT) and returned to the liver via portal blood.
- The liver extracts them efficiently → newly synthesised bile acids contribute <5% to biliary secretion under normal conditions.
- When the enterohepatic circulation is interrupted (e.g., by disease, ileal resection, or bile acid–binding resins like cholestyramine), fecal bile acid loss rises. This forces the liver to upregulate CYP7A1 and consume more cholesterol to replenish the pool → blood LDL cholesterol falls.
4. How This is Exploited Therapeutically
Bile acid sequestrants (cholestyramine, colesevelam) bind bile salts in the gut, prevent their reabsorption, and increase fecal excretion. The liver responds by:
- Upregulating CYP7A1 → more cholesterol converted to bile acids
- Upregulating LDL receptors (LDLR) → more LDL cleared from blood
Net result: lower serum LDL cholesterol.
5. Feedback Regulation of Bile Acid Synthesis (FXR–FGF19 Axis)
Bile acids themselves suppress their own synthesis. When ileal bile acid concentrations rise:
- Bile acids activate the nuclear receptor FXR (farnesoid X receptor) in enterocytes
- FXR stimulates release of fibroblast growth factor 19 (FGF19)
- FGF19 signals the liver to inhibit CYP7A1 → less bile acid synthesis from cholesterol
"Bile acids in the intestine stimulate the release of fibroblast growth factor 19 (FGF19), which suppresses the hepatic synthesis of bile acids from cholesterol by inhibiting the rate-limiting enzyme cytochrome P450 7A1."
— Harrison's Principles of Internal Medicine 22E
6. Biliary Cholesterol Secretion and Gallstones
Beyond being a substrate, cholesterol is also secreted directly into bile (via ABCG5/G8 transporters). Bile salts keep cholesterol soluble in bile by forming mixed micelles with phosphatidylcholine. The ratio of bile acids : phosphatidylcholine : cholesterol in canalicular bile is approximately 10 : 3 : 1.
- When bile salt secretion is low or biliary cholesterol is high, cholesterol supersaturates and crystallises → cholesterol gallstones
- The relationship between bile salt secretion rate and cholesterol secretion is curvilinear: at low bile salt secretion rates, more cholesterol is secreted per bile salt molecule than at higher rates.
Summary Table
| Relationship | Mechanism |
|---|
| Bile salts are synthesised from cholesterol | CYP7A1 (classical) and CYP27A1 (alternative) pathways |
| Bile acid loss → lower blood cholesterol | ↑ CYP7A1 activity + ↑ LDL receptor expression |
| Bile acid reabsorption → suppresses synthesis | FXR → FGF19 → inhibits CYP7A1 |
| Bile salt sequestrants lower LDL | Same as bile acid loss mechanism |
| Low bile salt pool → cholesterol gallstones | Loss of micellar solubilisation of biliary cholesterol |
Sources: Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Harrison's Principles of Internal Medicine 22E; Yamada's Textbook of Gastroenterology; Ganong's Review of Medical Physiology